A citation-based method for searching scientific literature

Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, Massimiliano Grassi, Veronica Murianni, Marco Tagliamento, Arsela Prelaj, Simona Coco, Luca Longo, Maria Giovanna Dal Bello, Angela Alama, Chiara Dellepiane, Elisa Bennicelli, Umberto Malapelle, Carlo Genova. Int J Mol Sci 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.
Liju Zong, Yuncan Zhou, Ming Zhang, Jie Chen, Yang Xiang. Cancer Immunol Immunother 2020
25
50

VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases.
Malte Borggrewe, Corien Grit, Wilfred F A Den Dunnen, Saskia M Burm, Jeffrey J Bajramovic, Randolph J Noelle, Bart J L Eggen, Jon D Laman. Glia 2018
23
50

Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis.
Xin-Lin He, Ying Zhou, Huan-Zi Lu, Qun-Xing Li, Zhi Wang. Sci Rep 2020
6
50

New emerging targets in cancer immunotherapy: the role of TIM3.
Alex Friedlaender, Alfredo Addeo, Giuseppe Banna. ESMO Open 2019
37
50

Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.
Elisa Agostinetto, Daniel Eiger, Kevin Punie, Evandro de Azambuja. Curr Oncol Rep 2021
3
50


VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.
Lawrence F Kuklinski, Shaofeng Yan, Zhongze Li, Jan L Fisher, Chao Cheng, Randolph J Noelle, Christina V Angeles, Mary Jo Turk, Marc S Ernstoff. Cancer Immunol Immunother 2018
35
50

Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity.
Dallas B Flies, Xue Han, Tomoe Higuchi, Linghua Zheng, Jingwei Sun, Jessica Jane Ye, Lieping Chen. J Clin Invest 2014
141
50

CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not?
Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, Katarzyna Magiera-Mularz, Dominik Sala, Miroslawa Czub, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka. Molecules 2019
59
50

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
Xing Huang, Xiaozhen Zhang, Enliang Li, Gang Zhang, Xun Wang, Tianyu Tang, Xueli Bai, Tingbo Liang. J Hematol Oncol 2020
23
50

VISTA: Coming of age as a multi-lineage immune checkpoint.
M A ElTanbouly, E Schaafsma, R J Noelle, J L Lines. Clin Exp Immunol 2020
22
50

Immune Checkpoint Therapies for Melanoma.
Elizabeth I Buchbinder. Hematol Oncol Clin North Am 2021
2
50

The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
Xiaoxue Xie, Junying Zhang, Zhongyuan Shi, Wanmei Liu, Xinlei Hu, Chenxin Qie, Wenting Chen, Yan Wang, Li Wang, Jingwei Jiang,[...]. Front Immunol 2020
11
50

VISTA is an immune checkpoint molecule for human T cells.
J Louise Lines, Eirini Pantazi, Justin Mak, Lorenzo F Sempere, Li Wang, Samuel O'Connell, Sabrina Ceeraz, Arief A Suriawinata, Shaofeng Yan, Marc S Ernstoff,[...]. Cancer Res 2014
237
50


Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
50

New emerging targets in cancer immunotherapy: the role of neoantigens.
Leticia De Mattos-Arruda, Juan Blanco-Heredia, Carmen Aguilar-Gurrieri, Jorge Carrillo, Julià Blanco. ESMO Open 2020
7
50


VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.
Liru Wang, Bei Jia, David F Claxton, W Christopher Ehmann, Witold B Rybka, Shin Mineishi, Seema Naik, Muhammad R Khawaja, Jeff Sivik, Junyan Han,[...]. Oncoimmunology 2018
50
50

VISTA expressed in tumour cells regulates T cell function.
Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Ryusuke Murakami,[...]. Br J Cancer 2019
56
50

Expression of the immune checkpoint VISTA in breast cancer.
Liju Zong, Shengwei Mo, Shuangni Yu, Yuncan Zhou, Ming Zhang, Jie Chen, Yang Xiang. Cancer Immunol Immunother 2020
19
50

High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study.
Sheng-Lan Ye, Xue-Ying Li, Ke Zhao, Tao Feng. Medicine (Baltimore) 2017
22
50


Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Apostolos Zaravinos, Constantinos Roufas, Majdi Nagara, Beatriz de Lucas Moreno, Maria Oblovatskaya, Christodoulos Efstathiades, Christos Dimopoulos, Georgios D Ayiomamitis. J Exp Clin Cancer Res 2019
27
50

Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Jorge Blando, Anu Sharma, Maria Gisela Higa, Hao Zhao, Luis Vence, Shalini S Yadav, Jiseong Kim, Alejandro M Sepulveda, Michael Sharp, Anirban Maitra,[...]. Proc Natl Acad Sci U S A 2019
121
50


Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.
Luka Brcic, Stefanie Stanzer, Dagmar Krenbek, Ulrike Gruber-Moesenbacher, Gudrun Absenger, Franz Quehenberger, Arschang Valipour, Joerg Lindenmann, Herbert Stoeger, Mohamed Al Effah,[...]. Virchows Arch 2018
12
50

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.
Karsten A Pilones, Michal Hensler, Camille Daviaud, Jeffrey Kraynak, Jitka Fucikova, Lorenzo Galluzzi, Sandra Demaria, Silvia C Formenti. Oncoimmunology 2020
7
50

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
Carlo Genova, Simona Boccardo, Marco Mora, Erika Rijavec, Federica Biello, Giovanni Rossi, Marco Tagliamento, Maria Giovanna Dal Bello, Simona Coco, Angela Alama,[...]. J Clin Med 2019
13
50

VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.
El Li Tham, Simon J Freeley, Siobhan Bearder, Fernanda Florez Barros, Mark S Cragg, Attila Mócsai, Michael G Robson. J Autoimmun 2020
1
100

FOXD3 Regulates VISTA Expression in Melanoma.
Sheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, Zhijiu Zhong, Dan A Erkes, Peter A McCue, Inna Chervoneva, Adam C Berger, Jennifer A Lo, David E Fisher,[...]. Cell Rep 2020
14
50

V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Stephanie Muller, W Victoria Lai, Prasad S Adusumilli, Patrice Desmeules, Denise Frosina, Achim Jungbluth, Ai Ni, Takashi Eguchi, William D Travis, Marc Ladanyi,[...]. Mod Pathol 2020
32
50

Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.
Li Wang, Isabelle Le Mercier, Juan Putra, Wenna Chen, Jun Liu, Austin D Schenk, Elizabeth C Nowak, Arief A Suriawinata, Jiannan Li, Randolph J Noelle. Proc Natl Acad Sci U S A 2014
96
50

Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nghia Nguyen, Emily Bellile, Daffyd Thomas, Jonathan McHugh, Laura Rozek, Shama Virani, Lisa Peterson, Thomas E Carey, Heather Walline, Jeffery Moyer,[...]. Head Neck 2016
168
50

Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Jun Liu, Ying Yuan, Wenna Chen, Juan Putra, Arief A Suriawinata, Austin D Schenk, Halli E Miller, Indira Guleria, Richard J Barth, Yina H Huang,[...]. Proc Natl Acad Sci U S A 2015
156
50

Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Joshua T Byers, Alessandro Paniccia, Jeffrey Kaplan, Michelle Koenig, Nate Kahn, Lora Wilson, Lieping Chen, Richard D Schulick, Barish H Edil, Yuwen Zhu. Ann Surg Oncol 2015
17
50

Tim-3 finds its place in the cancer immunotherapy landscape.
Nandini Acharya, Catherine Sabatos-Peyton, Ana Carrizosa Anderson. J Immunother Cancer 2020
53
50

Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
Andrew Gabrielson, Yunan Wu, Hongkun Wang, Jiji Jiang, Bhaskar Kallakury, Zoran Gatalica, Sandeep Reddy, David Kleiner, Thomas Fishbein, Lynt Johnson,[...]. Cancer Immunol Res 2016
153
50


Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer.
Franz Villarroel-Espindola, Xiaoqing Yu, Ila Datar, Nikita Mani, Miguel Sanmamed, Vamsidhar Velcheti, Konstantinos Syrigos, Maria Toki, Hongyu Zhao, Lieping Chen,[...]. Clin Cancer Res 2018
81
50

Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy.
Shanjuan Hong, Qing Yuan, Haizhui Xia, Genzhen Zhu, Yu Feng, Qiang Wang, Zhiyin Zhang, Wei He, Jian Lu, Chen Dong,[...]. Protein Cell 2019
12
50

Not All Immune Checkpoints Are Created Equal.
Annika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer, Peter Steinberger. Front Immunol 2018
71
50

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy.
Robert J Torphy, Richard D Schulick, Yuwen Zhu. Int J Mol Sci 2017
52
50

Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
Shan Xie, Jia Huang, Qin Qiao, Wenjuan Zang, Shanjuan Hong, Haidong Tan, Chen Dong, Zhiying Yang, Ling Ni. Cancer Immunol Immunother 2018
46
50

Characterization of programmed death-1 homologue-1 (PD-1H) expression and function in normal and HIV infected individuals.
Preeti Bharaj, Harendra Singh Chahar, Ogechika K Alozie, Lizette Rodarte, Anju Bansal, Paul A Goepfert, Alok Dwivedi, N Manjunath, Premlata Shankar. PLoS One 2014
35
50

VSIG-3 as a ligand of VISTA inhibits human T-cell function.
Jinghua Wang, Guoping Wu, Brian Manick, Vida Hernandez, Mark Renelt, Christian Erickson, Joanna Guan, Ravinder Singh, Simone Rollins, Alicia Solorz,[...]. Immunology 2019
86
50

B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.
Shuo Yang, Wei Wei, Qi Zhao. Int J Biol Sci 2020
50
50

High-Density Infiltration of V-domain Immunoglobulin Suppressor of T-cell Activation Up-regulated Immune Cells in Human Pancreatic Cancer.
Jinʼe Liu, Xiaoxue Xie, Chunxiao Xuan, Tingting Li, Lanlan Wang, Lianghong Teng, Jun Liu. Pancreas 2018
15
50

The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Jun Li, Jieyu Wang, Ruifang Chen, Yang Bai, Xin Lu. Oncotarget 2017
90
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.